Expand GSK Menu
GSK MENU

GSK Latest Press Releases

-- June 24, 2026 --

Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market Globe Newswire 8:30 AM

-- June 17, 2026 --

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs) Business Wire 4:21 PM
Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs) Globe Newswire 12:36 PM

-- June 10, 2026 --

Nuvalent Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nuvalent, Inc. - NUVL Business Wire 11:20 AM

-- June 9, 2026 --

Cancer's Toughest Targets Are Drawing Wall Street's Attention as Oncology Innovation Accelerates Globe Newswire 9:44 AM

-- May 7, 2026 --

Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults Business Wire 8:00 AM

-- March 13, 2026 --

GSK's RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18-49 Years at Increased Risk Business Wire 11:44 AM

-- March 11, 2026 --

Myriad Venture Partners Expands Executive Advisory Board as Enterprise AI Moves Into Production PRNewswire 6:00 AM

-- February 23, 2026 --

Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract Business Wire 1:15 PM

-- February 18, 2026 --

GSK's AREXVY Associated With Reductions in Certain RSV-Related Risks Including Heart Attack, Stroke and Severe Flare-Ups of COPD and Asthma, Real World Study Shows Business Wire 8:00 AM
Market Data Delayed 15 Minutes